IBJNews

Lilly, Roche dive deep into diagnostics

Back to TopCommentsE-mailPrintBookmark and Share

Two Indianapolis giants—Eli Lilly and Co. and Roche Diagnostics—are working hard to pair up drugs and diagnostic tests to gin up more sales.

Lilly, which launched its own diagnostic division last month to focus on cancer and Alzheimer’s drugs, has also found a test that could help its slow-selling blood thinner, Effient.

Indianapolis-based Lilly said Monday that its sales reps will talk up to doctors a blood test made by a San Diego firm that measures the clotting ability of each patient’s blood after taking a blood thinner. From Lilly’s standpoint, the idea is to identify which patients aren’t benefiting from Effient’s main competitor, Plavix.

Plavix’s annual sales of $9.5 billion dwarf those of Effient—$35 million in its first nine months on the market. But studies have shown that genetic variations cause as many as 14 percent of Plavix patients to receive little or no anti-clotting benefit from the drug.

Both Effient and Plavix are given to patients who have had their arteries propped open through balloon angioplasties or stents.

The diagnostic blood test, made by Accumetrics Inc., costs about $60, according to The New York Times. That’s cheaper and faster than a genetic test that could determine which patients won’t respond well to Plavix.

"We believe physicians will want to know the specific effect of a patient's antiplatelet [blood thinning] therapy and whether additional measures may be needed," said Dr. Rogelio Braceras, senior medical director of thrombosis at Lilly's development partner on Effient, Japan-based Daiichi Sankyo Inc.

Switzerland-based Roche, which operates both drug and diagnostic businesses, is testing one of its diagnostic tests against traditional Pap smears to see which detects the precursor of cervical cancer earliest. Roche Diagnostics' U.S. headquarters is in Indianapolis.

On July 9, Roche announced results of a clinical trial that showed its test, the cobas 4800 HPV Test, said one in 10 women who had the precursor to cervical cancer, the human papillomavirus, did not test positive for cancer in a Pap smear.

Roche’s test could potentially help sales of its blockbuster cancer drug Avastin. The drug is approved to treat various forms of cancer, and recent studies have examined it as a possible treatment for cervical cancer. Doctors have freedom to prescribe it for any treatment regimen.

Expect a lot more of these efforts in the future. An October study by consulting firm PricewaterhouseCoopers estimates the drug, device and diagnostic market at $24 billion a year and growing at 10 percent each of the next five years.

“This is kind of the next step,” said Tiffany Olson, Lilly’s vice president of diagnostics, in an interview at Lilly’s corporate headquarters south of downtown. “It’s making the promise actionable: right patient, right time, right dose."
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Hiking blocks to an office after fighting traffic is not logical. Having office buildings around the loop, 465 and in cities in surrounding counties is logical. In other words, counties around Indianapolis need office buildings like Keystone, Meridian, Michigan Road/College Park and then no need to go downtown. Financial, legal, professional businesses don't need the downtown when Carmel, Fishers, North Indy are building their own central office buildings close to the professionals. The more Hamilton, Boone county attract professionals, the less downtown is relevant. Highrises have no meaning if they don't have adequate parking for professionals and clients. Great for show, but not exactly downtown Chicago, no lakefront, no river to speak of, and no view from highrises of lake Michigan and the magnificent mile. Indianapolis has no view.

  2. "The car count, THE SERIES, THE RACING, THE RATINGS, THE ATTENDANCE< AND THE MANAGEMENT, EVERY season is sub-par." ______________ You're welcome!

  3. that it actually looked a lot like Sato v Franchitti @Houston. And judging from Dario's marble mouthed presentation providing "color", I'd say that he still suffers from his Dallara inflicted head injury._______Considering that the Formula E cars weren't going that quickly at that exact moment, that was impressive air time. But I guess we shouldn't be surprised, as Dallara is the only car builder that needs an FAA certification for their cars. But flying Dallaras aren't new. Just ask Dan Wheldon.

  4. Does anyone know how and where I can get involved and included?

  5. While the data supporting the success of educating our preschoolers is significant, the method of reaching this age group should be multi-faceted. Getting business involved in support of early childhood education is needed. But the ways for businesses to be involved are not just giving money to programs and services. Corporations and businesses educating their own workforce in the importance of sending a child to kindergarten prepared to learn is an alternative way that needs to be addressed. Helping parents prepare their children for school and be involved is a proven method for success. However, many parents are not sure how to help their children. The public is often led to think that preschool education happens only in schools, daycare, or learning centers but parents and other family members along with pediatricians, librarians, museums, etc. are valuable resources in educating our youngsters. When parents are informed through work lunch hour workshops in educating a young child, website exposure to exceptional teaching ideas that illustrate how to encourage learning for fun, media input, and directed community focus on early childhood that is when a difference will be seen. As a society we all need to look outside the normal paths of educating and reaching preschoolers. It is when methods of involving the most important adult in a child's life - a parent, that real success in educating our future workers will occur. The website www.ifnotyouwho.org is free and illustrates activities that are research-based, easy to follow and fun! Businesses should be encouraging their workers to tackle this issue and this website makes it easy for parents to be involved. The focus of preschool education should be to inspire all the adults in a preschooler's life to be aware of what they can do to prepare a child for their future life. Fortunately we now know best practices to prepare a child for a successful start to school. Is the business community ready to be involved in educating preschoolers when it becomes more than a donation but a challenge to their own workers?

ADVERTISEMENT